Related Experiment Videos
[Nonachlazine in solution as an arresting agent in stenocardiac attacks].
Farmakologiia I Toksikologiia
|May 1, 1979
Summary
Nonachlazine rapidly enters the bloodstream and organs. This drug increases coronary blood flow and oxygen levels, offering a potential treatment for angina pectoris unresponsive to nitroglycerin.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
Context:
- Angina pectoris is a common cardiovascular condition.
- Nitroglycerin is a standard treatment for angina.
- Some patients are unresponsive to nitroglycerin.
Purpose:
- To evaluate the efficacy and safety of nonachlazine for angina treatment.
- To investigate the pharmacokinetic and pharmacodynamic properties of nonachlazine.
Summary:
- Nonachlazine solution demonstrates rapid absorption into the bloodstream and organs.
- In feline models, gastric nonachlazine infusion increased coronary blood flow and oxyhemoglobin levels within minutes.
- The drug exhibited low toxicity and a slight increase in myocardial oxygen consumption.
Impact:
- Nonachlazine shows promise as an alternative therapeutic agent for managing angina pectoris in nitroglycerin-refractory patients.
- Further clinical studies are warranted to confirm its efficacy and safety in humans.